Biofermin Description

Manufacturer:

Distributor:

Zuellig Pharma

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Capsule: Each capsule is required to present a minimum Saccharomyces boulardii CNCM I-1079 of 5.0 x 10⁹ CFU.
Powder for oral suspension: Each sachet is required to present a minimum Saccharomyces boulardii CNCM I-1079 of 5.0 x 10⁹ CFU.
Saccharomyces boulardii CNCM I-1079 250 mg (non-lyophilised yeast cells).
Excipients/Inactive Ingredients: Capsule: Corn Starch, Magnesium Stearate, Silicon Dioxide.
Composition of the capsule shell: Hydroxypropyl methyl cellulose (HPMC).
Powder for oral suspension: Fructose, Banana Flavour, Silicon Dioxide.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in